Information about Rekambys (Rilpivirine)
Rekambys is a medication that contains the active ingredient rilpivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is primarily used in the treatment of HIV-1 (human immunodeficiency virus) infections. Rilpivirine works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV. It is commonly used in combination with other antiretroviral medications to help control HIV infection, reducing viral load and improving immune function.
Product Highlights
- Rekambys is indicated for the treatment of HIV-1 infection in adults and adolescents who are virologically suppressed (i.e., have an undetectable viral load) and are not infected with resistant strains of the virus.
- It is used alongside other antiretroviral medications to achieve improved viral suppression.
Key Ingredient
Key Benefits
- Rekambys helps lower the amount of HIV virus in the blood, contributing to better immune function and reducing the risk of transmission.
- The once-monthly injectable form provides convenience for patients who may find daily oral regimens challenging.
- As part of a combination therapy, Rekambys reduces the need for daily oral medications, improving adherence.
- When used in the appropriate patient population, Rekambys is generally well-tolerated, with fewer side effects compared to some older HIV medications.
Direction of Use
- Rekambys is administered as an intramuscular injection once a month by a healthcare provider.
- The dose and frequency are typically determined by a healthcare professional based on the patient's response to treatment and any potential drug interactions.
- It is used in combination with other HIV medications to provide comprehensive viral suppression.
Safety Concerns
- Rilpivirine may interact with other medications, potentially affecting its efficacy or causing side effects.
- Caution should be taken in patients with liver disease, as liver function may affect the metabolism of the drug.
- Some patients may develop skin rashes or allergic reactions.
- Rilpivirine has been associated with mood changes, depression, and suicidal thoughts in some individuals.
- Using Rekambys in patients with HIV strains that are resistant to rilpivirine may result in treatment failure.
Avoid Rekambys (Rilpivirine) If
- Avoid using Rekambys if the HIV strain is known to be resistant to rilpivirine.
- Patients with severe liver disease or cirrhosis may not be suitable candidates for this medication.
- While there are no conclusive studies on the use of Rekambys during pregnancy, it is important to consult a doctor for advice regarding its use in pregnant individuals.
- Do not use Rekambys if you are allergic to rilpivirine or any of the ingredients in the formulation.
